RxDoctor Payments Data

Cherrylene Lindgren, DO

Family Medicine · Lubbock, TXNPI 1043272834

Payments from drug & device makers

$637in general payments, 2019–2025

Across 44 payments — averaging $14.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$281
  • Sunovion Pharmaceuticals Inc.$163
  • AstraZeneca$50
  • GSK$50
  • Lilly USA, LLC$40
  • Sanofi-aventis U.S. LLC$29
  • plus $23 from 2 others

What the payments were for

  • Food & beverage$637100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$637 in reported general payments places this provider in the 55th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$36,460
Medicare patients
77
Services billed
964

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide77$81,630
JardianceEmpagliflozin50$60,135
JanuviaSitagliptin Phosphate41$31,126
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$24,441
EliquisApixaban16$13,702
Tresiba Flextouch U-100Insulin Degludec21$9,710
XareltoRivaroxaban13$8,429
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,604
Albuterol Sulfate HfaAlbuterol Sulfate109$4,060
SymbicortBudesonide/Formoterol Fumarate15$3,262
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate19$1,865
Solifenacin Succinate12$1,648
Levothyroxine Sodium163$1,451
Estradiol21$1,359
Atorvastatin Calcium244$1,255

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$281$81,63077 claims
Boehringer IngelheimJardiance$11$60,13550 claims
GSKTrelegy Ellipta, Anoro Ellipta$50$30,04541 claims
AstraZenecaSymbicort$50$3,26215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Lubbock

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →